EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
BXP, Inc.
EL7 Factor Analysis
How we score this
Overall34
Weak — below market medianHigh FlyerBetter than 34% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
39
34.8x▼17.8xBottom tier
▸
Growth
53
1.9%▼7.1%Around median
▸
Quality
60
8.0%▲4.5%Around median
▸
Safety
35
6.2x▼2.6xBottom tier
▸
Capital Return
15
—2.12%Bottom tier
▸
Momentum
57
0.9%▼2.9%Around median
▸
Sentiment
61
7▲3Around median
BXP

BXP BXP, Inc.

BXP, Inc. · NYSE
Market Closed
64.70
▲ ⁦+1.54%⁩ (+0.98)
Market Cap$10.3B
Beta1.04
52w Low52w High
49.7279.33
Last Week
⁦-3.52%⁩
Last Month
⁦-5.97%⁩
Last 3 Months
⁦+6.55%⁩
Last Year
⁦-7.15%⁩
Fair Value
Low confidenceCurrent price$65
Analyst target · 2 analysts
$70
⁦+8%⁩
See it undervalued
Range ⁦$61–$88⁩
vs
DCF (estimate)
$-68.06
⁦-205%⁩
Sees it clearly overvalued
⁦9.0⁩% discount · ⁦0⁩% growth
Bottom lineThe two methods disagree — estimate range ⁦$-68.06–$70⁩.

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener
Premium content

Get Your Premium Account Now

  • Stock Deep Analysis
  • The Advanced News Platform
Recommended
Annual plan
$17/mo
Monthly plan
$29/mo

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target· 2 analysts setting price target
$72.36
⁦+11.8%⁩
Current Price $64.70·Median $70.00
Low
$61.00
High
$88.00
Current price
$64.70
Average target
$72.36
Street summary

BXP Targets Stable with Clear Divergence

The consensus price target remained unchanged over the day and the last 7 days, staying at $72 among two analysts. Over the last 30 days, the consensus rose slightly from $71.4 to $72, an increase of 0.84%, while the current range stands between $61 and $88, reflecting wide divergence in estimates compared with the current price of $65.74.

As of 2026-09-08
Revisions momentum · 30d
⁦+1.3%⁩
Average rating
★ 3.77
Buy
Analyst coverage
22
Buy conviction
55%
Mixed
Rating activity · 30d
0↑ · 0↓
Target dispersion
42%
Wide
Analyst ratings over time22 analysts rating
5
7
10
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months3.68 → 3.77
Recent analyst moves
  • = Reiterate2026-09-01
    Wells Fargo
    Overweight
  • = Reiterate2026-08-25
    UBS
    Neutral
  • = Reiterate2026-08-12
    Deutsche Bank
    Hold
Premium content
Key Financials

Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.

StockSector medianSector averagetypical sector range
MetricValuePosition within sectorVerdict
  • P/E (TTM)
    34.78x
    5.03x40.26x
    Near median
  • Forward P/E
    33.38x
    5.89x47.13x
    Near median
  • EV / EBITDA
    11.24x
    3.68x29.40x
    Cheap
  • FCF Yield
    3.5%
    -23.1%16.7%
    Above average
  • Revenue Growth YoY
    1.9%
    -14.0%37.7%
    Near median
  • EPS Growth YoY
    9200.0%
    -121.8%181.8%
    Exceptional
  • Gross Margin
    46.1%
    -5.0%81.8%
    Above average
  • ROIC
    8.0%
    -4.2%9.5%
    Strong
  • Net Debt / EBITDA
    6.19x
    1.55x12.39x
    Low debt
  • Dividend Yield
    —
    —
  • Payout Ratio
    —
    —
  • Altman Z-Score
    —
    —
Financial Analysis
|

Stock Analysis

AI-generated
Based on 2026-07-29 data

Company Overview

BXP, Inc. is a real estate company focused on developing, owning, managing, and leasing premier office workplaces in knowledge centers and major urban markets, generating its income primarily from rents and services associated with its portfolio. It also deploys capital into office and residential development projects and sells land, homes, and non-strategic office assets to reduce leverage and finance higher-return projects. In the four central markets where it has a major presence, the direct vacancy rate for premier workplaces was 8% versus 13.5% for the broader office market, while the asking-rent premium exceeded 60% compared with non-premier buildings.

The latest available EDGAR filings show that fiscal year 2025 Q4 revenue was $877.1 million, gross profit was $515.8 million, and net income was $248.3 million, representing a gross margin of approximately 58.8% and a net margin of approximately 28.3%. For fiscal year 2025, BXP recorded revenue of $3.5 billion, gross profit of $2.1 billion, net income of $276.8 million, and earnings per share of $1.74, equivalent to a gross margin of approximately 60%. However, data for the twelve months ended in 2025 show a net loss of $200.4 million and negative earnings per share of approximately $1.27, an important divergence when assessing accounting earnings.

In fiscal year 2026 Q2, the company generated funds from operations of $1.78 per share, exceeding the midpoint of its guidance and analysts’ consensus by $0.08. Most of the outperformance came from portfolio net operating income; higher rental revenue added $0.03 per share, service income added $0.01, and lower operating expenses added $0.04. Occupancy rose to 88.4% from 87.4% in fiscal year 2026 Q1 and 86.7% at the end of fiscal year 2025, supported by leasing of 1.76 million square feet during the quarter.

What's Driving the Stock

  • BXP raised its fiscal year 2026 funds-from-operations guidance to $6.99–$7.05 per share, an increase of $0.05 at the midpoint, and raised its expected average annual occupancy by 65 basis points to 88.9%. It expects to end fiscal year 2026 near 90%.
  • Leasing activity reached 1.76 million square feet in fiscal year 2026 Q2, exceeding the ten-year historical average for the quarter by 29%, while the fiscal year-to-date total exceeded 3 million square feet. The company began fiscal year 2026 Q3 with signed but not yet occupied leases covering approximately 1.3 million square feet, with occupancy expected to commence on 1.1 million of those square feet during fiscal year 2026.
  • The 343 Madison Avenue project reached 50% committed occupancy following a 148 thousand-square-foot lease with McDermott Will & Emery and Starr’s two-floor expansion. BXP closed a $1.2 billion construction loan equal to 60% of the project’s cost after contracting 94% of construction costs within budget, targeting an unleveraged cash return of between 7.5% and 8% upon delivery in 2029.
  • The company delivered the 290 Binney Street project, a 570 thousand-square-foot laboratory fully leased to AstraZeneca, two months ahead of schedule and $20 million under budget. BXP’s $488 million investment in its stake generates an unleveraged cash return of 8.9% and an accounting return of 10.3%.
  • BXP signed a long-term 320 thousand-square-foot lease with Boston Dynamics to transform Reservoir Place into a robotics and artificial intelligence center; it will invest $87 million with an expected initial cash return exceeding 10%. Boston Dynamics also announced in connection with the lease that it expects to hire more than 1,000 new employees.
  • BXP generated net sale proceeds of $370 million since the beginning of fiscal year 2026 and more than $1.2 billion since its investor conference, and it has six assets under contract for sale with net proceeds of approximately $240 million. Cumulative sale proceeds could reach $1.7 billion by the end of fiscal year 2026, compared with a target of $1.9 billion by 2028.

Buying & Selling Case

▲ Buying Case4 pts

  • +Occupancy is improving faster than planned; BXP has already achieved 170 basis points of its 200-basis-point increase target for fiscal year 2026 and expects to add approximately 800 thousand square feet of occupancy and end the year near 90%.
  • +The company has a development pipeline of seven office and residential projects under construction, totaling 3.5 million square feet and an investment of $3.2 billion, with targeted or achieved returns ranging from 7.5% to more than 10% on the key projects mentioned.
  • +The premier portfolio benefits from limited new supply; vacancy in this category is only 8% in the four main central markets, asking rents at 343 Madison increased by 10%–15% from the previous year, and increases in the lower-priced portions of some Manhattan buildings reached approximately 20%.
  • +The asset-sale program strengthens financial flexibility and funds development and debt reduction; proceeds have exceeded $1.2 billion since the investor conference, while the target of reducing leverage to the low-seven-times range remains a stated priority.

▼ Selling Case6 pts

Valuation

Analysts’ consensus is “Buy,” with an average target of $71 and a wide range of between $61 and $88; the average is approximately 10.5% below the 52-week range high of $79.33, while the highest target exceeds that high. No positive price-to-earnings multiple is available, as fiscal year 2025 earnings per share were $1.74 but data for the twelve months ended in 2025 recorded negative earnings per share of approximately $1.27, making occupancy improvement, funds from operations, and refinancing risk more important than accounting net income alone when assessing the valuation.

BuyAnalyst target: $71(+9.7%)

Figures in the text are as of 2026-08-29; the live price is shown at the top of the page.

FAQ

What drove BXP’s results in fiscal year 2026 Q2?

BXP generated funds from operations of $1.78 per share, exceeding the midpoint of guidance and analysts’ consensus by $0.08. Higher rental revenue added $0.03 per share, service income added $0.01, and lower operating expenses added $0.04. Occupancy increased by 100 basis points during the quarter to 88.4%, driven by leasing activity of 1.76 million square feet.

Why is the 343 Madison Avenue project important to BXP stock?

343 Madison Avenue is BXP’s largest project under development, and it reached 50% contractually leased space in fiscal year 2026 Q2. The company closed a $1.2 billion construction loan equal to 60% of the project’s cost after contracting 94% of construction costs within budget. BXP targets an unleveraged cash return of between 7.5% and 8% upon delivery in 2029 and intends to monetize an aggregate stake of between 30% and 50% of the project over time.

How is artificial intelligence affecting tenant demand at BXP?

Management said on July 29, 2026 that BXP leases space to artificial intelligence companies in San Francisco, New York, and Seattle, as well as to companies that expanded or relocated because of the growth of those companies. One example is Boston Dynamics’ long-term lease for 320 thousand square feet at Reservoir Place, where a robotics and artificial intelligence center will be established. However, management acknowledged that the long-term impact of artificial intelligence is difficult to predict and that fading momentum would be negative, so it focuses on creditworthiness and letters of credit when leasing to startups.

Earnings callEDGAR filings30-day newsInsider activity

Automated analysis for informational purposes only — not investment advice.

  • −BXP faces a higher refinancing cost on a $1 billion unsecured bond due in October 2026 with an accounting interest rate of 3.5%; management estimated that a replacement ten-year bond would have been priced at approximately 6% under the market conditions it discussed on July 29, 2026.
  • −Accelerating leasing requires greater capital expenditure before cash rents are collected; management expects fiscal year 2026 leasing transaction costs to approach $500 million instead of $400 million, pressuring funds available for distribution during the year. New leases also typically include rent-free periods of between 6 and 12 months, so the company did not raise its expected cash net operating income growth despite raising its accounting-basis forecast by 30 basis points.
  • −Some markets and assets remain weaker than the core premier portfolio; management described laboratory demand in Urban Edge as sluggish and West LA as its weakest market for demand growth. Mountain View rents also declined from approximately $6 per square foot per month to around $4–$5, and the lower portions of some Embarcadero Center buildings face slight rental pressure.
  • −A reversal of the artificial intelligence boom could weaken office demand; management acknowledged during the July 29, 2026 call that the long-term impact of artificial intelligence is difficult to predict and that fading momentum would be negative. The company limits this risk by focusing on creditworthiness, letters of credit, and monitoring the proportion of the portfolio leased directly to artificial intelligence startups, but this does not eliminate the sector’s role in absorbing space in San Francisco and other markets.
  • −The asset-sale program accelerates deleveraging but dilutes funds from operations; management raised its estimated fiscal year 2026 impact from $0.06–$0.09 to approximately $0.11 per share if the expected sales are completed. The guidance update includes a $0.05-per-share reduction from lower net operating income on sold assets, partially offset by lower interest expense.
  • −No reliable positive price-to-earnings multiple is available, as data for the twelve months ended in 2025 showed a net loss of $200.4 million and negative earnings per share of approximately $1.27, despite fiscal year 2025 earnings per share of $1.74. This divergence makes it more difficult to use traditional accounting earnings to justify the valuation, while analysts’ targets range from $61 to $88.
  • Is the improvement in BXP’s portfolio occupancy sustainable?

    Occupancy rose from 86.7% at the end of fiscal year 2025 to 87.4% in fiscal year 2026 Q1 and then to 88.4% in fiscal year 2026 Q2. The company began fiscal year 2026 Q3 with approximately 1.3 million square feet signed but not occupied, with occupancy expected to commence on 1.1 million square feet during the fiscal year. Management targets the end of fiscal year 2026 near 90% and maintains a target of approximately 91% at the end of fiscal year 2027, with an estimated long-term stabilized ceiling of between 94% and 95%.

    How does BXP use asset sales in its financial plan?

    BXP generated net proceeds of $370 million since the beginning of fiscal year 2026 and more than $1.2 billion since its investor conference. On July 29, 2026, it had six assets under contract for sale with net proceeds of approximately $240 million, and cumulative proceeds could reach $1.7 billion by the end of fiscal year 2026. The company uses this liquidity to reduce debt and fund development, but accelerated sales could reduce funds from operations by approximately $0.11 per share in fiscal year 2026 if the expected transactions are completed.

    What are the main financial risks to monitor at BXP?

    A $1 billion unsecured bond with an accounting interest rate of 3.5% matures in October 2026, while management indicated that a replacement ten-year issuance would have been priced at approximately 6% under market conditions on July 29, 2026. The company also expects fiscal year 2026 leasing transaction costs to approach $500 million, with rent-free periods typically lasting between 6 and 12 months. In addition, data for the twelve months ended in 2025 showed a net loss of $200.4 million, despite recording net income of $276.8 million in fiscal year 2025.